Cargando…

A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer

BACKGROUND: Aurora A kinase, a centrosomal serine/threonine kinase which plays an essential role in chromosome segregation during cell division, is commonly amplified and/or over expressed in human malignancies. Aurora A is suggested to be one of the proliferation parameters which is an independent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Satoko, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Yutaka, Fujiwara, Saori, Iwase, Hirotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671980/ https://www.ncbi.nlm.nih.gov/pubmed/23627634 http://dx.doi.org/10.1186/1471-2407-13-217

Ejemplares similares

Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2015)

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2016)

An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
por: Sueta, Aiko, et al.
Publicado: (2014)

Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy
por: Omoto, Yoko, et al.
Publicado: (2015)

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
por: Suyama, Koichi, et al.
Publicado: (2017)

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
por: Tomiguchi, Mai, et al.
Publicado: (2016)

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence
por: Sueta, Aiko, et al.
Publicado: (2017)

The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer
por: Fujiwara, Saori, et al.
Publicado: (2014)

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2018)

Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer
por: Hayashi, Mitsuhiro, et al.
Publicado: (2015)

High density of CD204‐positive macrophages predicts worse clinical prognosis in patients with breast cancer
por: Miyasato, Yuko, et al.
Publicado: (2017)

The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
por: Shiota, Takuya, et al.
Publicado: (2016)

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival
por: Rezano, Andri, et al.
Publicado: (2013)

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2013)

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Fujiki, Yoshitaka, et al.
Publicado: (2018)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
por: Kosaka, Yoshimasa, et al.
Publicado: (2020)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

Targeted therapies for ER+/HER2- metastatic breast cancer
por: Yamamoto-Ibusuki, Mutsuko, et al.
Publicado: (2015)

A progressive and refractory case of breast cancer with Cowden syndrome
por: Sueta, Aiko, et al.
Publicado: (2022)

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
por: Yamamoto, Yutaka, et al.
Publicado: (2011)

The role of exosomal microRNAs; focus on clinical applications in breast cancer
por: Sueta, Aiko, et al.
Publicado: (2019)

A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character
por: Hayashi, Mitsuhiro, et al.
Publicado: (2013)

Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer
por: Kai, Kazuharu, et al.
Publicado: (2008)

GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development
por: Kuwahara, Kazuhiko, et al.
Publicado: (2016)

Physiological and Oncogenic Aurora-A Pathway
por: SAEKI, Toshiaki, et al.
Publicado: (2009)

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study
por: Iwase, H, et al.
Publicado: (2013)

A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation
por: Tomita, Saori, et al.
Publicado: (2015)

A measurement of beam size of AURORA by the use of SR-interferometer at SR Center of Ritsumeikan University
por: Mitsuhashi, T, et al.
Publicado: (1997)

Comprehensive serum and tissue microRNA profiling in dedifferentiated liposarcoma
por: Kohama, Isaku, et al.
Publicado: (2021)

The functional diversity of Aurora kinases: a comprehensive review
por: Willems, Estelle, et al.
Publicado: (2018)

Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial
por: Yamamoto, Daigo, et al.
Publicado: (2012)

The AURORA initiative for metastatic breast cancer
por: Zardavas, D, et al.
Publicado: (2014)

Identification of Aurora Kinase A as a Biomarker for Prognosis in Obesity Patients with Early Breast Cancer
por: Jiang, Junhan, et al.
Publicado: (2020)

Cyclin A is a reliable proliferation marker in endometrial cancer cell lines
por: Horie, Kayo, et al.
Publicado: (2019)

What is the Most Valid and Reliable Compassion Measure in Healthcare? An Updated Comprehensive and Critical Review
por: Sinclair, Shane, et al.
Publicado: (2022)

Aurora /
por: López Colomé, Pura, 1952-
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_h2hdjcpvjdtu7j80lvrf3n3nrq